An Early Robot Architecture for Cancer Healing

Abstract

Treating cancer tumors is a main goal of cancer research. The author of this paper identifies a new manner to treat cancer tumors more effectively using a recommended architecture of a nanorobot called CANBOT. It contains a number of nano-components: an actuator, temperature sensor, chemical sensor, and microcontroller. CANBOT starts its role by moving toward the tumor cells using the actuator. It senses the tumor cell by capturing its image and sensing its chemicals by the chemical sensor. When CANBOT distinguishes the tumor, it verifies the survival of the tumor cells by its temperature sensor. CANBOT increases the temperature of the tumor cell through the warmer. Sensing of the cancer chemicals starts over to detect the remaining existence of cancer cells. The suggested nanorobot injects the cell with the drug from a tiny tank throughout a nano pump with a small pine needle. A nano-microcontroller controls the mechanism of CANBOT formative the role of each one and the appropriate sequences. The position of the proposed nanorobot is simulated with reference to the position of the tumor using an analytical model. The conclusion is drawn that destroying the tumor requires instilling the robot into the cancer tumor directly for effective treatment. DOI: 10.4018/jcmam.2011100103 58 International Journal of Computational Models and Algorithms in Medicine, 2(4), 57-71, October-December 2011 Copyright © 2011, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited. Shirinzadeh, Freitas, & Kretly, 2007; Sierra, Weir, & Jones, 2005; Cavalcanti & Freitas, 2005; Mathieu, Martel, Yahia, Soulez, & Beaudoin, 2005; Behkam & Sitti, 2006; Xi, Schmidt, & Montemagno, 2005; Lee, Mahapatro, Caron, Requicha, Stauffer, Thompson, & Zhou, 2006; Fukuda, Kawamoto, Arai, & Matsuura, 1995; Freitas, 2005; Patel, Patel, Patel, Patel, & Patel, 2006; Ikeda, Arai, Fukuda, Kim, Negoro, Irie, & Takahashi, 2005; Xu, Vijaykrishnan, Xie, & Irwin, 2004; Park, Lee, & Lee, 2005; Couvreur & Vauthier, 2006; Gao, Wolfgang, Neschen, Morino, Horvath, Shulman, & Fu, 2004). The main objective of this paper is to match targeted therapies to cancer patients resourcefully and untimely using nanorobots. And the differentiated goal is to be able to abnegate tumor tissue in such a way as to abbreviate the bet of causing or allocating a recurrence of the growth in the body. The approach is conscious to be able to treat tumors that cannot be gained access via conventional surgery, such as abysmal brain tumors. Nanorobotics is the appearing technology area beginning apparatuses or robots whose components are at or access to the scale of a nanometer. More characteristically, nanorobotics refers to the nanotechnology engineering discipline of designing and creating nanorobots, with appliances ranging in amplitude from 0.110 micrometers and combined of nanoscale or molecular constituents. Nanomachines are amply in the research-and-development phase, although any primitive molecular machines have been analyzed. An archetypal is a sensor having a switch about 1.5 nanometers across, capable of counting specific molecules in a chemical archetypal. The first useful applications of nanomachines might be in medical technology, identify and destroy cancer cells (Cavalcanti, Shirinzadeh, Fukuda, & Ikeda, 2007; Leary, Liu, & Apuzzo, 2006; Boning, 2009; Boning, Ono, Nohara, & Dubowsky, 2008; Cavalcanti, Shirinzadeh, Freitas, & Kretly, 2007; Sierra, Weir, & Jones, 2005; Cavalcanti & Freitas, 2005; Mathieu, Martel, Yahia, Soulez, & Beaudoin, 2005; Behkam & Sitti, 2006; Xi, Schmidt, & Montemagno, 2005; Lee, Mahapatro, Caron, Requicha, Stauffer, Thompson, & Zhou, 2006; Fukuda, Kawamoto, Arai, & Matsuura, 1995; Freitas, 2005; Patel, Patel, Patel, Patel, & Patel, 2006; Ikeda, Arai, Fukuda, Kim, Negoro, Irie, & Takahashi, 2005; Xu, Vijaykrishnan, Xie, & Irwin, 2004; Park, Lee, & Lee, 2005; Couvreur & Vauthier, 2006; Gao, Wolfgang, Neschen, Morino, Horvath, Shulman, & Fu, 2004). Nanorobots interact with the cancer cells and based on molecular levels. The main component of the aimed nanorobot architecture is allotted in Section 2. The accomplished architecture design and the behavior of the proposed nanorobot is pioneered in Section 3. In Section 4 a verification of the proposed algorithms is presented. Section 5 demonstrates the system simulation and the results accrediting to the amplitudinous positions of the proposed nanorobot and the tumor. 2. LITERATURE REVIEW Previous researches presented the active components needed in our proposed nanorobot architecture. The proposed architecture consists of number of nano-components: a chemical sensor, a temperature sensor, an actuator and a micocontroller. These main components collaborate to achieve the goals of early detection and treatment of cancer tumor. The next subsections give a brief depiction about the structure and the functionality of these components. 2.1. Chemical Sensor The proposed nanorobot architecture uses the chemical sensors introduced in Cho, Lee, Kong, and Chandrakasan (2007). The basic idea of this type of chemical sensors is to source prearranged current to the carbon nanotube CNT sensors, and read the voltage residential across the sensors. This structural design is striking because the crossing point can vary the measurement ruling by changing the input current. This idea can be comprehensive over a proper current range to accomplish the necessary dynamic range since the system only needs 2% measurement precision across the preferred 13 more pages are available in the full version of this document, which may be purchased using the "Add to Cart" button on the product's webpage: www.igi-global.com/article/early-robot-architecture-cancerhealing/67530?camid=4v1 This title is available in InfoSci-Journals, InfoSci-Journal Disciplines Medicine, Healthcare, and Life Science. Recommend this product to your librarian: www.igi-global.com/e-resources/libraryrecommendation/?id=2